These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28731860)

  • 1. The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
    Li W; Saweris M; Madhira B
    Am J Ther; 2018; 25(5):e606-e607. PubMed ID: 28731860
    [No Abstract]   [Full Text] [Related]  

  • 2. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Gordon PH; Frucht SJ
    Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Parenteral Nutrition and Neuroleptic Malignant-Like Syndrome in Parkinson Disease.
    Fernandes JPS
    Am J Ther; 2022 Nov-Dec 01; 29(6):e709-e710. PubMed ID: 33021549
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 77-year-old man with Parkinson's disease and hyperthermia.
    Madigan EJ
    J Emerg Nurs; 2008 Jun; 34(3):229-30. PubMed ID: 18558256
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Mizuno Y; Takubo H; Mizuta E; Kuno S
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal pseudo-obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient.
    Shimada J; Sakakibara R; Uchiyama T; Liu Z; Yamamoto T; Ito T; Mori M; Asahina M; Hattori T
    Eur J Neurol; 2006 Mar; 13(3):306-7. PubMed ID: 16618352
    [No Abstract]   [Full Text] [Related]  

  • 11. Care of Parkinson's disease (PD) patients in times of covid-19 pandemic.
    Chattopadhyay S
    Diabetes Metab Syndr; 2021; 15(4):102168. PubMed ID: 34198109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome after withdrawal of levopoda].
    Cedeno-Veloz B; Areosa Sastre A
    Rev Esp Geriatr Gerontol; 2018; 53(5):299-300. PubMed ID: 29628214
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK; Seegers S
    Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome-like condition in multiple system atrophy.
    Konagaya M; Goto Y; Matsuoka Y; Konishi T; Konagaya Y
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):120-1. PubMed ID: 9221984
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    Iwuagwu CU; Riley D; Bonoma RA
    Am J Med; 2000 Apr; 108(6):517-8. PubMed ID: 10866587
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C; Scheinost NA; Lefeber EJ
    Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors.
    Grace JB; Thompson P
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):193-4. PubMed ID: 16440373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant-like neuroleptic syndrome: a sign to call attention to].
    Segado Soriano A; García Castaño J; del Toro Cervera J; Muiño Miguez A
    An Med Interna; 1995 Sep; 12(9):466-7. PubMed ID: 8924562
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Akai M; Ishizaki T; Idemura Y; Sasaki F; Nakai T; Miyaho S; Matsubara R; Uchiki H; Nakaguki K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1863-4. PubMed ID: 1479229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.